Form 4: Hims & Hers CCO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc.'s Chief Commercial Officer, Michael Chi, sold 13,749 shares of Class A Common Stock for $50.5 per share, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., reported a sale of company stock.
• The transaction involved the disposition of 13,749 shares of Class A Common Stock.
• The shares were sold at a price of $50.5 per share.
• The total value of the shares sold is approximately $694,124.50.
• Following this transaction, Michael Chi beneficially owns 297,139 shares of Class A Common Stock.
• The sale was executed on September 17, 2025.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Michael Chi on March 4, 2025.

Sentiment

Score: 5

Explanation: Neutral, as the transaction is a pre-planned insider sale under a Rule 10b5-1 plan, which typically does not indicate a change in management's outlook on the company's prospects. Such sales are often for personal financial planning.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is an individual insider transaction and does not directly relate to broader industry trends or competitor performance. Insider sales under Rule 10b5-1 plans are a common practice for executives to manage personal finances while complying with insider trading regulations.

Stakeholder Impact

• Shareholders may note the insider sale, but the pre-arranged nature of the 10b5-1 plan generally mitigates concerns about management's confidence in the company's future.

Key Dates

Recommendation

The sale by the Chief Commercial Officer was executed under a pre-arranged Rule 10b5-1 trading plan, which suggests it is part of a personal financial management strategy rather than a reflection of a change in the company's fundamental outlook. Such planned sales are common and do not typically warrant a change in investment recommendation unless they are unusually large or frequent, or occur outside of a 10b5-1 plan. This transaction represents a relatively small portion of the officer's total holdings.

Keywords

Hims & Hers Health, HIMS, Michael Chi, Chief Commercial Officer, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Transaction